STING1 and cancer: Combined expression analysis of cGAS and STING showed a significantly higher percentage of patients with MSI-H mCRC with a fully or partially activated cGAS-STING signalling pathway in cancer cells (chi-square test, p = 0.0050) (Figure 2).